X
Record #18832

A novel derivative of betulinic acid, SYK023, suppresses lung cancer growth and malignancy

Journal
Oncotarget
Original paper date
May 30, 2015
Institution
Center for Infection Disease and Signal Research, College of Medicine, National Cheng Kung University, Tainan, Taiwan · Institute of Bioinformatics and Biosignal Transduction, College of Bioscience and Biotechnology, National Cheng Kung University, Tainan, Taiwan · Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan · Department of Internal Medicine, College of Medicine and Hospital, National Cheng Kung University, Tainan, Taiwan · Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, Tainan, Taiwan · Natural Products Research Laboratories, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA · Laboratory of Pharmacognosy, Graduate School of Pharmaceutical Sciences, The University of Tokushima, Tokushima, Japan · Chinese Medicine Research and Development Center, China Medical University and Hospital, Taichung, Taiwan · Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan · Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan
Open access
No
Article type
Research Article
Broad categories
(BLS) Biochemistry(BLS) Biology - Cancer(BLS) Biology - Cellular(BLS) Toxicology
Notes from Retraction Watch

date of retraction unknown, article removed from TOC; returned to website on unknown date; later updated to a correction;

Citation lifecycle

How this paper is being cited

Pre-retraction
8
Same day
0
Post-retraction
20
% post-retraction
71.4%
~2.5 citations/yr before retraction · ~2.4 citations/yr after
— citing papers

Who is still citing this work

Loading…
Back to browse